Prevalence of ESBL-positive Enterobacteriaceae in large Moravian hospitals (Czech Republic);Prevalence ESBL-pozitivních enterobakterií ve velkých moravských nemocnicích

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 16, Issue 5, 2010, Pages 152-157

  Kolar M ^a   Chroma M ^a   Hricova K ^a   Husičková, Vendula ^a   Loveckova Y ^a   Chmelarova E ^b   Bartonikova N ^c   Rybnikarova P ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b Zdravotní Ústav Ostrava ^*  (Czech Republic)

^c Plicní Odd lení Krajská Nemocnice T Bati Zlín   (Czech Republic)

Author keywords

Enterobacteriaceae; ESBL; Hospitals; Prevalence

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CZECH REPUBLIC; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENETIC ANALYSIS; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN;

BETA-LACTAMASES; CROSS INFECTION; CZECH REPUBLIC; ENTEROBACTERIACEAE INFECTIONS; HUMANS; PREVALENCE;

EID: 78650823980     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Peterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev. 2005; 18: 657-686.
2. Livermore DM, Canton R, Gniadkowski M, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007;59:165-174.
3. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983;11:315-317. (Pubitemid 14213754)
4. Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1985;28:302-307. (Pubitemid 15019966)
5. EARSS. European Antimicrobial Resistance Surveillance System. http://www.rivm.nl/earss/.
6. Ko KS, Lee MY, Song JH, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn Microbiol Infect Dis. 2008; 61: 453-459.
7. Scicluna EA, Haider J, Borg MA, Cuschieri P. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Maltese hospitalized patients. J Hosp Infect. 2007;65:86-88. (Pubitemid 44932966)
8. Batchoun RG, Swedan SF, Shurman AM. Extended spectrum beta-lactamases among gram-negative bacterial isolates from clinical specimens in three major hospitals in northern Jordan. Int J Microbiol. 2009; 2009: 513874.
9. Goyal A, Prasad KN, Prasad A, et al. Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors. Indian J Med Res. 2009; 129.695-700.
10. Akpaka PE, Swanston WH. Phenotypic detection and occurrence of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli at a tertiary hospital in Trinidad & Tobago. Braz J Infect Dis. 2008;12:516-520.
11. Ozgunes I, Erben N, Kiremitci A, et al. The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors. Saudi Med J. 2006;27:608-612.
12. Carattoli A, García-Fernández A, Varesi P, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy. J Clin Microbiol. 2008;46:103-108.
13. Hanberger H, Arman D, Gill H, et al. Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control. Intensive Care Med. 2009;35:91-100.
14. Kesselová M, Kolář M, Sauer P, et al. Molecular biology characteristics of ESBL-positive strains of Klebsiella pneumoniae collected in the Neonatal Unit of the Teaching Hospital in Olomouc. Klin Mikrobiol Inf Lék. 2005;11:20-24.
15. Chromá M, Kolář M, Sauer P, Marek O, Koukalová D. Molekulárno-biologická analýza ESBL-pozitívnych izolátov Klebsiella pneumoniae od pacientov v intenzívnej starostlivosti. Klin Mikrobiol Inf Lék. 2007;13:206-211.
16. Kolář M, Látal T, Čermák P, et al. Prevalence ESBL-pozitivních kmenů Klebsiella pneumoniae v České republice a jejich molekulárně- biologická analýza. Klin Mikrobiol Inf Lék. 2005;11:92-99.
17. Kang CI, Kim SH, Park WB, et al. Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase- producing Escherichia coli and Klebsiella pneumoniae. Korean J Intern Med. 2004;19:160-164.
18. Tumbarello M, Sanguinetti M, Montuori E, et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta- lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother. 2007;51:1987-1994.
19. Schwaber MJ, Navon-Venezia S, Kaye KS, et al. Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2006;50:1257-1262.
20. Bennett PM. Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol. 2008;153:S347-S357.
21. Ploy NC, Lambert T, Gassama A, Denis F. Place des intégrons dans la dissémination de la resistance aux antibiotiques. Ann Biol Clin. 2000;58:439-444. (Pubitemid 30650010)
22. CLSI. Performance standards for antimicrobial susceptibility testing, seventeenth informational supplement. M100-S17. 2007.
23. The European Committee on Antimicrobial Susceptibility Testing. http://www.eucast.org/.
24. Kolář M. Klinický význam š irokospektrých β-laktamáz a zkušenosti s jejich identifikací v mikrobiologické praxi. Klin Mikrobiol Inf Lék. 2007;13:195-205.
25. Arlet G, Brami G, Décrè D, et al. Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamases. FEMS Microbiol Lett. 1995;134:203-208.
26. Chanawong A, M'Zali FH, Heritage J, Lulitanond A, Hawkey PM. Characterisation of extended-spectrum β-lactamases of the SHV family using a combination of PCR-single strand conformational polymorphism (PCR-SSCP) and PCR-restriction fragment length polymorphism (PCR-RFLP). FEMS Microbiol Lett. 2000;184:85-89.
27. Pagani L, Dell'Amico E, Migliavacca R, et al. Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J Clin Microbiol. 2003;41:4264-4269. (Pubitemid 37099694)
28. Fang H, Ataker F, Hedin G, Dornbusch K. Molecular epidemiology of extended-spectrum beta-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol. 2008;46:707-712.
29. Zhanel GG, DeCorby M, Nichol KA, et al. Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN- ICU) study (2005-2006). Can J Infect Dis Med Microbiol. 2008;19:243-249.